PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
23-Sep-2024 Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine Vicebio Ltd
23-Sep-2024 Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Sanofi
23-Sep-2024 Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering Zenas BioPharma
23-Sep-2024 Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant Sanofi
23-Sep-2024 Biocomposites to showcase innovations in infection management at EBJIS 2024 Biocomposites
23-Sep-2024 Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia Teva Pharmaceutical Industries Ltd
23-Sep-2024 Fasenra recommended for approval in the EU by CHMP for the treatment of eosinophilic granulomatosis with polyangiitis AstraZeneca
23-Sep-2024 Mölnlycke Health Care partners with Ondine for Steriwave distribution collaboration in the key markets of the UK, Europe and the Middle East Ondine Biomedical Inc
23-Sep-2024 2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA Association of the British Pharmaceutical Industry (ABPI)
23-Sep-2024 Terumo Blood and Cell Technologies collaborates with Nova Biomedical to bring automated cell culture sensing to Quantum Flex Terumo Blood and Cell Technologies
23-Sep-2024 European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement The European Microbiome Innovation for Health
23-Sep-2024 Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer Theriva™ Biologics, Inc.
23-Sep-2024 ABPI welcomes Chancellor’s speech at Labour party conference ABPI
23-Sep-2024 Neuraxpharm Receives Positive CHMP Opinion for the Extension of Indication of Epilepsy Treatment Buccolam® to Adults Neuraxpharm Group (Neuraxpharm)
20-Sep-2024 Cancer Pain Market is expected to reach USD 8.26 Billion by 2030 at a CAGR of 4.8 percent MAXIMIZE MARKET RESEARCH PVT. LTD.
19-Sep-2024 Bayer submits application to MHRA for elinzanetant to treat moderate to severe vasomotor systems associated with menopause in women Bayer
19-Sep-2024 Biocomposites acquires remaining shares in manufacturers of SYNICEMTM and Subiton products Biocomposites
19-Sep-2024 New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment TG THERAPEUTICS
19-Sep-2024 Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease Tiziana Life Sciences
19-Sep-2024 Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer Autolus Therapeutics plc